Travel and Leisure Travel and Leisure

Trump turbulence stalls large pharma and biotech deals, bankers say


Published on 2025-03-26 07:01:01 - Reuters
  Print publication without navigation

  • Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House economic policies that have roiled markets and set off a global trade war, according to four top healthcare investment bankers.

The article from Reuters discusses how the uncertainty surrounding former President Donald Trump's potential return to office is causing hesitation among pharmaceutical and biotech companies in pursuing large mergers and acquisitions. According to bankers, the fear stems from Trump's previous policies, including his criticism of high drug prices and threats to impose price controls, which could significantly impact the profitability and valuation of deals. This political uncertainty has led to a slowdown in deal-making, with companies and investors adopting a cautious approach, waiting to see the outcomes of the U.S. election before committing to major transactions. The article also notes that while there is still interest in smaller, strategic deals, the market for blockbuster mergers has cooled, with potential buyers and sellers wary of the regulatory and policy changes that might follow a Trump presidency.

Read the Full Reuters Article at:
[ https://www.reuters.com/business/healthcare-pharmaceuticals/trump-turbulence-stalls-large-pharma-biotech-deals-bankers-say-2025-03-26/ ]
Similar Travel and Leisure Articles
[ Tue, Jan 14th ] - Reuters
[ Mon, Oct 19th 2009 ] - Market Wire
[ Tue, Sep 29th 2009 ] - Market Wire
[ Tue, Sep 08th 2009 ] - Market Wire
[ Thu, Aug 27th 2009 ] - Market Wire
[ Tue, Aug 11th 2009 ] - Market Wire
[ Mon, Jul 20th 2009 ] - Market Wire
[ Tue, Jul 14th 2009 ] - Market Wire
[ Thu, Jun 18th 2009 ] - Market Wire
[ Thu, Jun 11th 2009 ] - Market Wire
[ Tue, May 19th 2009 ] - Market Wire
[ Mon, Dec 01st 2008 ] - Market Wire